No Data
No Data
H.C. Wainwright Maintains MoonLake Immunotherapeutics(MLTX.US) With Buy Rating, Maintains Target Price $100
Insider Trading Activity Heats Up: Tuesday's Top Buys and Sells in US Stocks
Biotechnology Value Fund L.P. Reduces Stake in MoonLake Immunotherapeutics
MoonLake Immunotherapeutics(MLTX.US) 10% Shareholder Sells US$100 Million in Common Stock
$MoonLake Immunotherapeutics(MLTX.US)$ 10% Shareholder BVF PARTNERS L P/IL sold 2 million shares of common stock on Oct 4, 2024 at an average price of $50.0016 for a total value of $100 million.
MoonLake Immunotherapeutics(MLTX.US) Director Sells US$9.19 Million in Common Stock
$MoonLake Immunotherapeutics(MLTX.US)$ Director Sturge Simon sold 171K shares of common stock on Oct 4, 2024 at an average price of $53.72 for a total value of $9.19 million.Source: Announcement
Moonlake Immunotherapeutics Insider Sold Shares Worth $9,186,120, According to a Recent SEC Filing